Sage Journals: Discover world-class research

Abstract

The pharmaceutical industry is among the most admired and most criticised of all. This dichotomy stems from the fact that the industry, on the one hand, provides cure to life-threatening disease, but is incapable of providing cure to everyone at affordable prices. The most ardent critics of the industry demand no less than fulfilling this unique ethical mandate. Some years ago, the pharmaceutical industry started flirting with the fairly young and attractive concept of corporate social responsibility (CSR), and the two have been a fairly stable couple ever since. However, where is their relationship going? This review summarises the potential and limits of CSR, examines case studies and discusses the features of successful CSR actions in the pharmaceutical industry. Moreover, future trends in CSR and current challenges are identified. In conclusion, the couple pharmaceutical industry and CSR appears to hold all the keys in their hands to steer their relationship into more romantic waters.

Keywords

Corporate Social Responsibility business ethics pharmaceutical industry

Get full access to this article

View all access options for this article.

References

Hager

(2002) We are not the problem – Chief Concern – pharmaceutical industry initiatives – Brief Article. Chief Executive Publishing, Gale Group http://findarticles.com/p/articles/mi_m4070/is2002_July/ai_89394645/print, BNET Business Network, accessed 14 September 2008.

Lefebvre

Miller

(2006) Pharmaceutical giants and corporate social responsibility: A hard pill to swallow. Corporate Social Responsibility, Rockhurst University. http://www.rockhurst.edu/news/events/images/projecti/lefebvre.pdf, Rockhurst University, accessed 14 September 2008.

Khanna

A. K

. (2006) Pharmaceutical industry's corporate social responsibility towards HIV/AIDS. Journal of Postgraduate Medicine 52: 194–196.

Corporate Watch. Corporate Crimes. Pharmaceutical Industry: Sector Overview. http://www.corporatewatch.org.uk/?lid=315, Corporate Watch, London, UK. Accessed 14 September 2008.

Finegold

(2005) BioIndustry Ethics. Burlington, MA, USA; San Diego, CA, USA; London, UK: Elsevier Academic Press.

Kotler

Lee

(2005) Corporate Social Responsibility – Doing the Most Good for Your Company and Your Cause. John Wiley & Sons, Inc.: Hoboken, NJ, USA.

European Commission. Definition of corporate social responsibility. http://europa.eu/scadplus/leg/en/lvb/n26034.htm, European Commission, accessed on 14 September 2008.

Flaherty

(1998) Summary of stakeholder dialogue session (The Netherlands, 6–8 September 1998), Geneva, September 1998, as found in WBCSD, Meeting Changing Expectations, Corporate Social Responsibility. World Business Council for Sustainable Development (WBCSD).

Vogel

(2006) The Market for Virtue – The Potential and Limits of Corporate Social Responsibility. Washington, DC, USA: Brookings Institution Press.

10.

Kermani

(2005) Why corporate social responsibility is healthy for pharma. http://www.pharmiweb.com/features/feature.asp?ROW_ID=630, PharmiWeb.com, accessed 14 September 2008.

11.

World Business Council for Sustainable Development publications. Corporate social responsibility: Making good business sense (2000). http://www.wbcsd.org/web/publications/csr2000.pdf.

12.

The Business Case for CSR. (2001) http://www.wbcsd.org/web/publications/business-case.pdf, World Business Council for Sustainable Development, Accessed 14 September 2008.

13.

LEEM – Les Entreprises du Médicament (The French Pharmaceutical Companies Association). (2007) Responsabilité Sociétal des Entreprises du Médicament, Rapport 2007.

14.

Business & Society Magazine, Belgium. (2003) Belgian business network for corporate social responsibility. 12 (Nov), 15–16.

15.

Alfonso

F. B.

Sharma

(2005) Is responsibility on the menu? Managers must understand what corporate social responsibility programs mean for all aspects of the business, and any CSR initiative must be led from the top. Communication World, May–June 2005. http://findarticles.com/p/articles/mi_m4422/is_3_22/ai_n13667321/print?tag=artBody;col1, BNET Business Network, accessed 14 September 2008.

16.

Bluestone

Heaton

Lewis

(2002) Beyond philanthropy: The pharmaceutical industry, corporate social responsibility and the developing world. An Oxfam/Save the Children/VSO joint report. http://www.atmindex.org/download/38, Access to Medicine Foundation, accessed 14 September 2008.

17.

Kermani

(2006) Why corporate social responsibility makes sense – CSR is in the best interest of the public at large … and the pharmaceutical company itself. http://actmagazine.findpharma.com/appliedclinicaltrials/article/articleDetail.jsp?id=324326, Applied Clinical Trials Online, Accessed 14 September 2008.

18.

Esteban

(2008) Strengthening corporate social responsibility in the pharmaceutical industry. Journal of Medical Marketing 8: 77–79.

Ethical Corporate Social Responsibility (CSR) and the Pharmaceutical Industry: A Happy Couple?

Abstract

Keywords

Get full access to this article

References